Armistice Capital »

MasTec shares owned by Armistice Capital

Quarter-by-quarter ownership of MasTec (MTZ) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in MasTec

Tip: Access up to 7 years of quarterly data

All positions including MasTec held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in MasTec by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $875k 2.1k 416.06

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding MasTec

BlackRock
Peconic Partners
Vanguard Capital Management
Vanguard Portfolio Management
Hill City Capital
State Street Corporation
Lone Pine Capital
Bank of America Corporation
First Trust Advisors
Jpmorgan Chase & Co
Geode Capital Management
Invesco
Victory Capital Management
Hood River Capital Management
FMR

View all funds holding MasTec